Advertisement

Vancomycin-resistant Enterococci

  • Esteban C. Nannini
  • Barbara E. Murray
Chapter
Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC, volume 2)

Conclusion

The incidence of nosocomial infections caused by VRE has consistently increased during the past decade across all types of health-care facilities, especially in the United States. More rigorous infection control measures and reduction in the use of antimicrobials for the treatment of human infections and/or new preventative modalities will likely be necessary to decrease the development of drug resistance in enterococci, as well as in other microorganisms. Restriction of the use of antibiotics as animal growth enhancers in the EU has resulted in decreased transmission of these organisms (and their resistant genes) from animals to humans. This interchange between animals and humans has become even more worrisome after a recent description of an E. faecium outbreak causing severe hemorrhagic disease in pigs and 40 local farmers (12 of them died) in a region of China (Lu et al., 2002). Newer therapeutic agents have been developed and used with relative effectiveness (although without a bactericidal activity) for the treatment of VRE infections, but the propensity of enterococci to develop resistance suggest that VRE will continue to be a therapeutic and infection control challenge for the immediate future.

Keywords

Antimicrob Agent Vancomycin Resistance National Nosocomial Infection Surveillance Infect Control Hosp Glycopeptide Resistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aarestrup, F. M., Seyfarth, A. M., Emborg, H. D., Pedersen, K., Hendriksen, R. S., & Bager, F. (2001). Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 45, 2054–2059.PubMedCrossRefGoogle Scholar
  2. Allen, N. E., LeTourneau, D. L., & Hobbs, J. N., Jr. (1997). The role of hydrophobic side chains as determinants of antibacterial activity of semisynthetic glycopeptide antibiotics. J Antibiot (Tokyo) 50, 677–684.Google Scholar
  3. Allerberger, F., & Klare, I. (1999). In-vitro activity of fosfomycin against vancomycin-resistant enterococci. J Antimicrob Chemother 43, 211–217.PubMedCrossRefGoogle Scholar
  4. Arias, C. A., Courvalin, P., & Reynolds, P. E. (2000). vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174. Antimicrob Agents Chemother 44, 1660–1666.PubMedCrossRefGoogle Scholar
  5. Arthur, M., & Courvalin, P. (1993). Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 37, 1563–1571.PubMedGoogle Scholar
  6. Arthur, M., Depardieu, F., Cabanie, L., Reynolds, P., & Courvalin, P. (1998). Requirement of the VanY and VanX D,D-peptidases for glycopeptide resistance in enterococci. Mol Microbiol 30, 819–830.PubMedCrossRefGoogle Scholar
  7. Arthur, M., Depardieu, F., Molinas, C., Reynolds, P., & Courvalin, P. (1995). The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 154, 87–92.PubMedCrossRefGoogle Scholar
  8. Arthur, M., Depardieu, F, Reynolds, P., & Courvalin, P. (1996). Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol Microbiol 21, 33–44.PubMedCrossRefGoogle Scholar
  9. Arthur, M., Depardieu, F., Reynolds, P., & Courvalin, P. (1999). Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci. Antimicrob Agents Chemother 43, 1875–1880.PubMedGoogle Scholar
  10. Arthur, M., Molinas, C., & Courvalin, P. (1992). The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacterial 174, 2582–2591.Google Scholar
  11. Arthur, M., Molinas, C., Depardieu, F, & Courvalin, P. (1993). Characterization of Tn1546, aTn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacterial 175, 117–127.Google Scholar
  12. Arthur, M., & Quintiliani, R., Jr. (2001). Regulation of VanA-and VanB-type glycopeptide resistance in enterococci. Antimicrob Agents Chemother 45, 375–381.PubMedCrossRefGoogle Scholar
  13. Aslangul, E., Baptista, M., Fantin, B., Depardieu, F., Arthur, M., Courvalin, P., & Carbon, C. (1997). Selection of glycopeptide-resistant mutants of VanB-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis. J Infect Dis 175, 598–605.PubMedGoogle Scholar
  14. Austin, D. J., Bonten, M. J., Weinstein, R. A., Slaughter, S., & Anderson, R. M. (1999). Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci USA 96, 6908–6913.PubMedGoogle Scholar
  15. Axelrod, P., & Talbot, G. H. (1989). Risk factors for acquisition of gentamicin-resistant enterococci. A multivariate analysis. Arch Intern Med 149, 1397–1401.PubMedCrossRefGoogle Scholar
  16. Babcock, H. M., Ritchie, D. J., Christiansen, E., Starlin, R., Little, R., & Stanley, S. (2001). Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin Infect Dis 32, 1373–1375.PubMedCrossRefGoogle Scholar
  17. Baden, L. R., Thiemke, W., Skolnik, A., Chambers, R., Strymish, J., Gold, H. S., Moellering, Jr, R. C., & Eliopoulos, G. M. (2001). Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of clearance. Clin Infect Dis 33, 1654–1660.PubMedCrossRefGoogle Scholar
  18. Balas, D., Perea, B., Wilhelmi, I., Romanyk, J., Alos, J. I., & Gomez-Garces, J. L. (1997). Prevalence of antimicrobial resistance in enterococci isolated from blood in Madrid (1994–1995). Enferm Infecc Microbiol Clin 15, 22–23.PubMedGoogle Scholar
  19. Balzereit-Scheuerlein, F., & Stephan, R. (2001). Prevalence of colonisation and resistance patterns of vancomycin-resistant enterococci in healthy, non-hospitalised persons in Switzerland. Swiss Med Wkly 131, 280–282.PubMedGoogle Scholar
  20. Bates, J., Jordens, J. Z., & Griffiths, D. T. (1994). Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 34, 507–514.PubMedGoogle Scholar
  21. Bell, J., Turnidge, J., Coombs, G., & O’Brien, F. (1998). Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun Dis Intell 22, 249–252.PubMedGoogle Scholar
  22. Bignardi, G. E. (1998). Risk factors for Clostridium difficile infection. J Hasp Infect 40, 1–15.Google Scholar
  23. Bingen, E., Lambert-Zechovsky, N., Mariani-Kurkdjian, P., Cezard, J. P., & Navarro, J. (1989). Bacteremia caused by a vancomycin-resistant Enterococcus. Pediatr Infect Dis J 8, 475–476.PubMedGoogle Scholar
  24. Bingen, E. H., Denamur, E., Lambert-Zechovsky, N. Y, & Elion, J. (1991). Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J Clin Microbiol 29, 1888–1892.PubMedGoogle Scholar
  25. Bonilla, H. F., Zervos, M. A., Lyons, M. J., Bradley, S. F., Hedderwick, S. A., Ramsey, M. A., Paul, L. K., & Kauffman, C. A. (1997). Colonization with vancomycin-resistant Enterococcus faecium: Comparison of a long-term-care unit with an acute-care hospital. Infect Control Hosp Epidemiol 18, 333–339.PubMedGoogle Scholar
  26. Bonten, M. J., Hayden, M. K., Nathan, C., van Voorhis, J., Matushek, M., Slaughter, S., Rice, T., & Weinstein, R. A. (1996). Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348, 1615–1619.PubMedCrossRefGoogle Scholar
  27. Bonten, M. J., Slaughter, S., Ambergen, A. W., Hayden, M. K., van Voorhis, J., Nathan, C., & Weinstein, R. A. (1998). The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: An important infection control variable. Arch Intern Med 158, 1127–1132.PubMedCrossRefGoogle Scholar
  28. Bouza, E., San Juan, R., Munoz, P., Voss, A., & Kluytmans, J. (2001). A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect 7, 523–531.PubMedGoogle Scholar
  29. Boyce, J. M. (1989). Methicillin-resistant Staphylococcus aureus. Detection, epidemiology, and control measures. Infect Dis Clin North Am 3, 901–913.PubMedGoogle Scholar
  30. Boyce, J. M., Mermel, L. A., Zervos, M. J., Rice, L. B., Potter-Bynoe, G., Giorgio, C., & Medeiros, A. A. (1995). Controlling vancomycin-resistant enterococci [see comments] [erratum appears in Infect Control Hosp Epidemiol 1996 Apr;17(4), 211]. Infect Control Hosp Epidemiol 16, 634–637.PubMedGoogle Scholar
  31. Boyce, J. M., Opal, S. M., Chow, J. W., Zervos, M. J., Potter-Bynoe, G., Sherman, C. B., Romulo, R. L., Fortna, S., & Medeiros, A. A. (1994). Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 32, 1148–1153.PubMedGoogle Scholar
  32. Boyd, D. A., Conly, J., Dedier, H., Peters, G., Robertson, L., Slater, E., & Mulvey, M. R. (2000). Molecular characterization of the vanD gene cluster and a novel insertion element in a vancomycin-resistant Enterococcus isolated in Canada. J Clin Microbiol 38, 2392–2394.PubMedGoogle Scholar
  33. Bozdogan, B., & Leclercq, R. (1999). Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. Antimicrob Agents Chemother 43, 2720–2725.PubMedGoogle Scholar
  34. Bradley, S. J., Wilson, A. L., Allen, M. C., Sher, H. A., Goldstone, A. H., & Scott, G. M. (1999). The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematologyunit by changing antibiotic usage. J Antimicrob Chemother 43, 261–266.PubMedCrossRefGoogle Scholar
  35. Brandt, C. M., Rouse, M. S., Laue, N. W., Stratton, C. W., Wilson, W. R., & Steckelberg, J. M. (1996). Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis 173, 909–913.PubMedGoogle Scholar
  36. Brennen, C., Wagener, M. M., & Muder, R. R. (1998). Vancomycin-resistant Enterococcus faecium in a long-term care facility. J Am Geriatr Soc 46, 157–160.PubMedGoogle Scholar
  37. Brooks, S., Khan, A., Stoica, D., Griffith, J., Friedeman, L., Mukherji, R., Hameed, R., & Schupf, N. (1998). Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers. Infect Control Hasp Epidemiol 19, 333–336.Google Scholar
  38. Brown, A. R., Townsley, A. C., & Amyes, S. G. (2001). Diversity of Tn1546 elements in clinical isolates of glycopeptide-resistant enterococci from Scottish hospitals. Antimicrob Agents Chemother 45, 1309–1311.PubMedCrossRefGoogle Scholar
  39. Budavari, S. M., Saunders, G. L., Liebowitz, L. D., Khoosal, M., & Crewe-Brown, H. H. (1997). Emergence of vancomycin-resistant enterococci in South Africa. S Afr Med J 87, 1557.PubMedGoogle Scholar
  40. Byers, K. E., Anglim, A. M., Anneski, C. J., Germanson, T. P., Gold, H. S., Durbin, L. J., Simonton, B. M., & Farr, B. M. (2001). A hospital epidemic of vancomycin-resistant Enterococcus: Risk factors and control. Infect Control Hosp Epidemiol 22, 140–147.PubMedGoogle Scholar
  41. Byers, K. E., Durbin, L. J., Simonton, B. M., Anglim, A. M., Adal, K. A., & Farr, B. M. (1998). Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 19, 261–264.PubMedGoogle Scholar
  42. Caballero-Granado, F. J., Becerril, B., Cuberos, L., Bernabeu, M., Cisneros, J. M., & Pachon, J. (2001). Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia. Clin Infect Dis 32, 587–594.PubMedCrossRefGoogle Scholar
  43. Caballero-Granado, F. J., Cisneros, J. M., Luque, R., Torres-Tortosa, M., Gamboa, F., Diez, F., Villanueva, J. L., Perez-Cano, R., Pasquau, J., Merino, D., Menchero, A., Mora, D., Lopez-Ruz, M. A., & Vergara, A. (1998). Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The grupo Andaluz para el estudio de las enfermedades infecciosas. J Clin Microbiol 36, 520–525.PubMedGoogle Scholar
  44. Canepari, P., Boaretti, M., del Mar Lleo, M., & Satta, G. (1990). Lipoteichoic acid as a new target for activity of antibiotics: Mode of action of daptomycin (LY146032). Antimicrob Agents Chemother 34, 1220–1226.PubMedGoogle Scholar
  45. Carias, L. L., Rudin, S. D., Donskey, C. J., & Rice, L. B. (1998). Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate. J Bacteriol 180, 4426–4434.PubMedGoogle Scholar
  46. Caron, F., Gold, H. S., Wennersten, C. B., Farris, M. G., Moellering, R. C., Jr., & Eliopoulos, G. M. (1997). Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 41, 2749–2753.PubMedGoogle Scholar
  47. Caron, F., Pestel, M., Kitzis, M. D., Lemeland, J. F., Humbert, G., & Gutmann, L. (1995). Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis 171, 106–112.PubMedGoogle Scholar
  48. Casadewall, B., & Courvalin, P. (1999). Characterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339. J Bacteriol 181, 3644–3648.PubMedGoogle Scholar
  49. CDC. (1994). Preventing the Spread of Vancomycin Resistance—A Report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Microorganisms in Hospitals; comment period and public meeting—CDC. Notice. Federal Register 59, 25758–25763.Google Scholar
  50. CDC. (2002a). Staphylococcus aureus resistant to vancomycin—United States, 2002. MMWR 51, 565–567.Google Scholar
  51. CDC. (2002b). Vancomycin-resistant Staphylococcus aureus—Pennsylvania, 2002. MMWR 51, 902.Google Scholar
  52. CDC. (1995). Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 44, 1–13.Google Scholar
  53. Chia, J. K., Nakata, M. M., Park, S. S., Lewis, R. P., & McKee, B. (1995). Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 21, 1520.PubMedGoogle Scholar
  54. Chien, J. W., Kucia, M. L., & Salata, R. A. (2000). Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant Gram-positive bacterial infections. Clin Infect Dis 30, 146–151.PubMedCrossRefGoogle Scholar
  55. Chiew, Y. E, & Ling, M. L. (1998). Two cases of vancomycin-resistant enterococci from Singapore. J Infect 36, 133–134.PubMedCrossRefGoogle Scholar
  56. Chirurgi, V. A., Oster, S. E., Goldberg, A. A., & McCabe, R. E. (1992). Nosocomial acquisition of beta-lactamase—negative, ampicillin-resistant Enterococcus. Arch Intern Med 152, 1457–1461.PubMedCrossRefGoogle Scholar
  57. Chow, J. W., Davidson, A., Sanford, E., 3rd, & Zervos, M. J. (1997). Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy. Clin Infect Dis 24, 91–92.PubMedGoogle Scholar
  58. Clabots, C. R., Johnson, S., Olson, M. M., Peterson, L. R., & Gerding, D. N. (1992). Acquisition of Clostridium difficile by hospitalized patients: Evidence for colonized new admissions as a source of infection. J Infect Dis 166, 561–567.PubMedGoogle Scholar
  59. Clark, N. C., Teixeira, L. M., Facklam, R. R., & Tenover, F.C. (1998). Detection and differentiation of vanC-1, vanC-2, and vanC-3 glycopeptide resistance genes in enterococci. J Clin Microbiol 36, 2294–2297.PubMedGoogle Scholar
  60. Collins, L. A., Malanoski, G. J., Eliopoulos, G. M., Wennersten, C. B., Ferraro, M. J., & Moellering, R. C., Jr. (1993). In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant Gram-positive organisms. Antimicrob Agents Chemother 37, 598–601.PubMedGoogle Scholar
  61. Coque, T. M., Tomayko, J. F., Ricke, S. C., Okhyusen, P. C., & Murray, B. E. (1996). Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 40, 2605–2609.PubMedGoogle Scholar
  62. Coudron, P. E., Markowitz, S. M., & Wong, E. S. (1992). Isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob Agents Chemother 36, 1125–1126.PubMedGoogle Scholar
  63. Coudron, P. E., Mayhall, C. G., Facklam, R. R., Spadora, A. C., Lamb, V A., Lybrand, M. R., & Dalton, H. P. (1984). Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol 20, 1044–1048.PubMedGoogle Scholar
  64. Das, I., & Gray, J. (1998). Enterococcal bacteremia in children: A review of seventy-five episodes in a pediatric hospital. Pediatr Infect Dis J 17, 1154–1158.PubMedCrossRefGoogle Scholar
  65. Dembry, L. M., Uzokwe, K., & Zervos, M. J. (1996). Control of endemic glycopeptide-resistant enterococci. Infect Control Hosp Epidemiol 17, 86–292.Google Scholar
  66. Descheemaeker, P., Ieven, M., Chapelle, S., Lammens, C., Hauchecorne, M., Wijdooghe, M., Vandamme, P., & Goossens, H. (2000). Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units. J Infect Dis 181, 235–241.PubMedCrossRefGoogle Scholar
  67. Dever, L. L., Smith, S. M., Handwerger, S., & Eng, R. H. (1995). Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy. J Clin Microbiol 33, 2770–2773.PubMedGoogle Scholar
  68. Devriese, L. A., Vandamme, P., Pot, B., Vanrobaeys, M., Kersters, K., & Haesebrouck, F. (1998). Differentiation between Streptococcus gallolyticus strains of human clinical and veterinary origins and Streptococcus bovis strains from the intestinal tracts of ruminants. J Clin Microbiol 36, 3520–3523.PubMedGoogle Scholar
  69. Dodge, R. A., Daly, J. S., Davaro, R., & Glew, R. H. (1997). High-dose ampicillin plus streptomycin for treatment of a patient with severe infection due to multi-resistant enterococci. Clin Infect Dis 25, 1269–1270.PubMedGoogle Scholar
  70. Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000a). Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients [see comments]. N Engl J Med 343, 1925–1932.PubMedCrossRefGoogle Scholar
  71. Donskey, C. J., Hanrahan, J. A., Hutton, R. A., & Rice, L. B. (1999a). Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 180, 384–390.PubMedCrossRefGoogle Scholar
  72. Donskey, C. J., Hanrahan, J. A., Hutton, R. A., & Rice, L. B. (2000b). Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 181, 1830–1833.PubMedCrossRefGoogle Scholar
  73. Donskey, C. J., Schreiber, J. R., Jacobs, M. R., Shekar, R., Salata, R. A., Gordon, S., Whalen, C. C., Smith, F., & Rice, L. B. (1999b). A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio vancomycin-resistant Enterococcus surveillance program. Clin Infect Dis 29, 573–579.PubMedGoogle Scholar
  74. Dunne, W. M. (1996). Watch out where the huskies go. ASM News 62, 283.Google Scholar
  75. Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V S., Jr., & Swartz, M. N. (1993). Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 328, 21–28.PubMedCrossRefGoogle Scholar
  76. Dutka-Malen, S., Blaimont, B., Wauters, G., & Courvalin, P. (1994). Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliftavus. Antimicrob Agents Chemother 38, 1675–1677.PubMedGoogle Scholar
  77. Dutka-Malen, S., Molinas, C., Arthur, M., & Courvalin, P. (1992). Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a d-alanine: d-alanine ligase-related protein necessary for vancomycin resistance. Gene 112, 53–58.PubMedCrossRefGoogle Scholar
  78. Edmond, M. B., Ober, J. F., Dawson, J. D., Weinbaum, D. L., & Wenzel, R. P. (1996). Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality. Clin Infect Dis 23, 1234–1239.PubMedGoogle Scholar
  79. Edmond, M. B., Ober, J. F., Weinbaum, D. L., Pfaller, M. A., Hwang, T., Sanford, M. D., & Wenzel, R. P. (1995). Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection. Clin Infect Dis 20, 1126–1133.PubMedGoogle Scholar
  80. Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999). Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis 29, 239–244.PubMedGoogle Scholar
  81. Eliopoulos, G. M., Wennersten, C., Zighelboim-Daum, S., Reiszner, E., Goldmann, D, & Moellering, R. C., Jr. (1988). High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother 32, 1528–1532.PubMedGoogle Scholar
  82. Eliopoulos, G. M., Wennersten, C. B., Gold, H. S., Schulin, T., Souli, M., Farris, M. G., Cerwinka, S., Nadler, H. L., Dowzicky, M., Talbot, G. H., & Moellering, R. C., Jr. (1998). Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. Antimicrob Agents Chemother 42, 1088–1092.PubMedGoogle Scholar
  83. Endtz, H. P., van den Braak, N., van Belkum, A., Kluytmans, J. A., Koeleman, J. G., Spanjaard, L., Voss, A., Weersink, A. J., Vandenbroucke-Grauls, C. M., Buiting, A. G., van Duin, A., & Verbrugh, H. A. (1997). Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol 35, 3026–3031.PubMedGoogle Scholar
  84. Evers, S., & Courvalin, P. (1996). Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583. J Bacteriol 178, 1302–1309.PubMedGoogle Scholar
  85. Facklam, R., Hollis, D., & Collins, M. D. (1989). Identification of Gram-positive coccal and coccobacillary vancomycin-resistant bacteria. J Clin Microbiol 27, 724–730.PubMedGoogle Scholar
  86. Fantin, B., Leclercq, R., Garry, L., & Carbon, C. (1997). Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis. Antimicrob Agents Chemother 41, 931–935.PubMedGoogle Scholar
  87. Fines, M., Perichon, B., Reynolds, P., Sahm, D. F., & Courvalin, P. (1999). VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 43, 2161–2164.PubMedGoogle Scholar
  88. Finland, M., Wilcox, C., & Frank, P. F. (1950). In vitro sensitivity of human pathogens strains of streptococci to seven antibiotics. Am J Clin Pathol 20, 208–217.PubMedGoogle Scholar
  89. Fontana, R., Cerini, R., Longoni, P., Grossato, A., & Canepari, P. (1983). Identification of a streptococcal penicillin-binding protein that reacts very slowly with penicillin. J Bacteriol 155, 1343–1350.PubMedGoogle Scholar
  90. Fontana, R., Ligozzi, M., Pedrotti, C., Padovani, E. M., & Cornaglia, G. (1997). Vancomycin-resistant Bacillus circulans carrying the vanA gene responsible for vancomycin resistance in enterococci. Eur J Clin Microbiol Infect Dis 16, 473–474.PubMedCrossRefGoogle Scholar
  91. Fraimow, H. S., Jungkind, D. L., Lander, D. W., Delso, D. R., & Dean, J. L. (1994). Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann Intern Med 121, 22–26.PubMedGoogle Scholar
  92. Fridkin, S. K., Edwards, J. R., Courval, J. M., Hill, H., Tenover, F. C., Lawton, R., Gaynes, R. P., & McGowan, J. E., Jr. (2001). The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 135, 175–183.PubMedGoogle Scholar
  93. Fridkin, S. K., Yokoe, D. S., Whitney, C. G., Onderdonk, A., & Hooper, D. C. (1998). Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts. J Clin Microbiol 36, 965–970.PubMedGoogle Scholar
  94. Frieden, T. R., Munsiff, S. S., Low, D. E., Willey, B. M., Williams, G., Faur, Y, Eisner, W., Warren, S., & Kreiswirth, B. (1993). Emergence of vancomycin-resistant enterococci in New York City. Lancet 342, 76–79.PubMedCrossRefGoogle Scholar
  95. Fujita, N., Yoshimura, M., Komori, T., Tanimoto, K., & Ike, Y. (1998). First report of the isolation of high-level vancomycin-resistant Enterococcus faecium from a patient in Japan. Antimicrob Agents Chemother 42, 2150.PubMedGoogle Scholar
  96. Furlong, W. B., & Rakowski, T. A. (1997). Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns. Clin Infect Dis 25, 163–164.PubMedGoogle Scholar
  97. Gales, A. C., & Jones, R. N. (2000). Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates. Diagn Microbiol Infect Dis 36, 19–36.PubMedGoogle Scholar
  98. Garbutt, J. M., Ventrapragada, M., Littenberg, B., & Mundy, L. M. (2000). Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 30, 466–72.PubMedCrossRefGoogle Scholar
  99. Geraci, J. E., & Martin, W. J. (1954). Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis: Clinical, pathologic and therapeutic consideration of 33 cases. Circulation 10, 173–194.PubMedGoogle Scholar
  100. Gerding, D. N. (1997). Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 25(Suppl 2), S206–210.Google Scholar
  101. Gerding, D. N., Buxton, A. E., Hughes, R. A., Cleary, P. P., Arbaczawski, J., & Stamm, W. E. (1979). Nosocomial multiply resistant Klebsiella pneumoniae: Epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother 15, 608–615.PubMedGoogle Scholar
  102. Goldstein, F. W. (2000). Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 19, 112–117.PubMedCrossRefGoogle Scholar
  103. Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001). Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357, 1179.PubMedCrossRefGoogle Scholar
  104. Goodall, B., & Tompkins, D. S. (1994). Methicillin resistant staphylococcal infection. Nursing homes act as reservoir, [letter; comment], BMJ 308, 58.PubMedGoogle Scholar
  105. Gordon, S., Swenson, J. M., Hill, B. C., Pigott, N. E., Facklam, R. R., Cooksey, R. C., Thornsberry, C., Jarvis, W. R., & Tenover, F. C. (1992). Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol 30, 2373–2378.PubMedGoogle Scholar
  106. Grayson, M. L., Eliopoulos, G. M., Wennersten, C. B., Ruoff, K. L., De Girolami, P. C., Ferraro, M. J., & Moellering, R. C. (1991). Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: A 22-year review at one institution. Antimicrob Agents Chemother 35, 2180–2184.PubMedGoogle Scholar
  107. Green, M., Barbadora, K., & Michaels, M. (1991). Recovery of vancomycin-resistant Gram-positive cocci from pediatric liver transplant recipients. J Clin Microbiol 29, 2503–2506.PubMedGoogle Scholar
  108. Green, M., Shlaes, J. H., Barbadora, K., & Shlaes, D. M. (1995). Bacteremia due to vancomycin-dependent Enterococcus faecium. Clin Infect Dis 20, 712–714.PubMedGoogle Scholar
  109. Grosso, M. D., Caprioli, A., Chinzari, P., Fontana, M. C., Pezzotti, G., Manfrin, A., Giannatale, E. D., Goffredo, E., & Pantosti, A. (2000). Detection and characterization of vancomycin-resistant enterococci in farm animals and raw meat products in Italy. Microb Drug Resist 6, 313–318.PubMedGoogle Scholar
  110. Hachem, R., Afif, C., Gokaslan, Z., & Raad, I. (2001). Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid. Eur J Clin Microbiol Infect Dis 20, 432–434.PubMedCrossRefGoogle Scholar
  111. Handwerger, S., Raucher, B., Altarac, D., Monka, J., Marchione, S., Singh, K. V, Murray, B. E., Wolff, J., & Walters, B. (1993). Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 16, 750–755.PubMedGoogle Scholar
  112. Handwerger, S., & Skoble, J. (1995). Identification of chromosomal mobile element conferring highlevel vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 39, 2446–2453.PubMedGoogle Scholar
  113. Handwerger, S., & Tomasz, A. (1985). Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis 7, 368–386.PubMedGoogle Scholar
  114. Haroche, J., Allignet, J., Aubert, S., Van Den Bogaard, A. E., & El Solh, N. (2000). satG, conferring resistance to streptogramin A, is widely distributed in Enterococcus faecium strains but not in staphylococci. Antimicrob Agents Chemother 44, 190–191.PubMedCrossRefGoogle Scholar
  115. Hartman, C. S., Leach, T. S., Kaja, R. W., Schaser, R. J., Todd, W. M., & Hafkin, B. (2000, September 17–20). Linezolid in the treatment of vancomycin-resistant Enterococcus: A dose comparative, multicenter phase III trial. Proceedings of 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract No. 2235), Toronto, Canada. Washington, DC: American Society for Microbiology.Google Scholar
  116. Hayden, M. K. (2000). Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin Infect Dis 31, 1058–1065.PubMedCrossRefGoogle Scholar
  117. Hayden, M. K., Trenholme, G. M., Schultz, J. E., & Sahm, D. F. (1993). In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J Infect Dis 167, 1224–1227.PubMedGoogle Scholar
  118. Herrero, I. A., Issa, N. C., & Patel, R. (2002). Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med 346, 867–869.PubMedCrossRefGoogle Scholar
  119. Herwaldt, L. A. (1999). Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am J Med 106, 11S–18S; discussion 48S–52S.PubMedCrossRefGoogle Scholar
  120. Herzstein, J., Ryan, J. L., Mangi, R. J., Greco, T. P., & Andriole, V T. (1984). Optimal therapy for enterococcal endocarditis. Am J Med 76, 186–191.PubMedCrossRefGoogle Scholar
  121. Horodniceanu, T., Bougueleret, L., El-Solh, N., Bieth, G., & Delbos, F. (1979). High-level, plasmidborne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob Agents Chemother 16, 686–689.PubMedGoogle Scholar
  122. Howe, R. A., Robson, M., Oakhill, A., Cornish, J. M., & Millar, M. R. (1997). Successful use of tetracycline as therapy of an immunocompromised patient with septicaemia caused by a vancomycin-resistant Enterococcus. J Antimicrob Chemother 40, 144–145.PubMedGoogle Scholar
  123. Iwen, P. C., Kelly, D. M., Linder, J., Hinrichs, S. H., Dominguez, E. A., Rupp, M. E., & Patil, K. D. (1997). Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob Agents Chemother 41, 494–495.PubMedGoogle Scholar
  124. Jensen, L. B., Ahrens, P., Dons, L., Jones, R. N., Hammerum, A. M., & Aarestrup, F. M. (1998a). Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J Clin Microbiol 36, 437–442.PubMedGoogle Scholar
  125. Jensen, L. B., Hammerum, A. M., Aerestrup, F. M., van den Bogaard, A. E., & Stobberingh, E. E. (1998b). Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in the Netherlands. Antimicrob Agents Chemother 42, 3330–3331.PubMedGoogle Scholar
  126. Johnson, A. P., Uttley, A. H., Woodford, N., & George, R. C. (1990). Resistance to vancomycin and teicoplanin: An emerging clinical problem. Clin Microbiol Rev 3, 280–291.PubMedGoogle Scholar
  127. Johnson, S., & Gerding, D. N. (1998). Clostridium difficile—Associated diarrhea. Clin Infect Dis 26, 1027–1034; quiz 1035–1026.PubMedGoogle Scholar
  128. Jones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997). Nosocomial enterococcal blood stream infections in the SCOPE Program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis 29, 95–102.PubMedGoogle Scholar
  129. Karanfil, L. V., Murphy, M., Josephson, A., Gaynes, R., Mandel, L., Hill, B. C., & Swenson, J. M. (1992). A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 13, 195–200.PubMedGoogle Scholar
  130. Kawalec, M., Gniadkowski, M., Kedzierska, J., Skotnicki, A., Fiett, J., & Hryniewicz, W. (2001). Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the VanB phenotype. J Clin Microbiol 39, 4274–4282.PubMedGoogle Scholar
  131. Kim, K. H., Fekety, R., Batts, D. H., Brown, D., Cudmore, M., Silva, J., Jr., & Waters, D. (1981). Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 143, 42–50.PubMedGoogle Scholar
  132. Kim, W. J., Weinstein, R. A., & Hayden, M. K. (1999). The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis 179, 163–171.PubMedCrossRefGoogle Scholar
  133. Kirkpatrick, B. D., Harrington, S. M., Smith, D., Marcellus, D., Miller, C., Dick, J., Karanfil, L., & Perl, T. M. (1999). An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. Clin Infect Dis 29, 1268–1273.PubMedCrossRefGoogle Scholar
  134. Kirst, H. A., Thompson, D. G., & Nicas, T. I. (1998). Historical yearly usage of vancomycin. Antimicrob Agents Chemother 42, 1303–1304.PubMedGoogle Scholar
  135. Kjerulf, A., Pallesen, L., & Westh, H. (1996). Vancomycin-resistant enterococci at a large university hospital in Denmark. APMIS 104, 475–479.PubMedCrossRefGoogle Scholar
  136. Klare, I., Badstubner, D., Konstabel, C., Bohme, G., Claus, H., & Witte, W. (1999). Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 5, 45–52.PubMedGoogle Scholar
  137. Krogstad, D. J., & Pargwette, A. R. (1980). Defective killing of enterococci: A common property of antimicrobial agents acting on the cell wall. Antimicrob Agents Chemother 17, 965–968.PubMedGoogle Scholar
  138. Lafaurie, M., Perichon, B., Lefort, A., Carbon, C., Courvalin, P., & Fantin, B. (2001). Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis. Antimicrob Agents Chemother 45, 2826–2830.PubMedCrossRefGoogle Scholar
  139. Laganas, V., & Silverman, J. A. (2001, December 16–19). Inhibition of lipoteichoic acid biosynthesis is not the target of daptomycin in Staphylococcus aureus. Proceedings of 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract No. C1-1802). Chicago, IL. Washington, DC: American Society for Microbiology.Google Scholar
  140. Lai, K. K. (1996). Treatment of vancomycin-resistant Enterococcus faecium infections. Arch Intern Med 156, 2579–2584.PubMedCrossRefGoogle Scholar
  141. Lai, K. K., Kelley, A. L., Melvin, Z. S., Belliveau, P. P., & Fontecchio, S. A. (1998). Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect Control Hosp Epidemiol 19, 647–652.PubMedGoogle Scholar
  142. Lautenbach, E., Bilker, W. B., & Brennan, P. J. (1999). Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 20, 318–323.PubMedGoogle Scholar
  143. Lautenbach, E., Schuster, M. G., Bilker, W. B., & Brennan, P. J. (1998). The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus. Clin Infect Dis 27, 1259–1265.PubMedGoogle Scholar
  144. Leach, T. S., Schaser, R. J., Hempsall, K. A., & Todd, W. M. (2000). Clinical efficacy of linezolid for infections caused by vancomycin-resistant enterococci (VRE) in a compassionate-use program (abstract no. 66). Clin Infect Dis 31, 224.Google Scholar
  145. Leber, A. L., Hindler, J. F., Kato, E. O., Bruckner, D. A., & Pegues, D. A. (2001). Laboratory-based surveillance for vancomycin-resistant enterococci: Utility of screening stool specimens submitted for Clostridium difficile toxin assay. Infect Control Hosp Epidemiol 22, 160–164.PubMedGoogle Scholar
  146. Leclercq, R., Bingen, E., Su, Q. H., Lambert-Zechovski, N., Courvalin, P., & Duval, J. (1991). Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci. Antimicrob Agents Chemother 35, 92–98.PubMedGoogle Scholar
  147. Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988). Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 319, 157–161.PubMedCrossRefGoogle Scholar
  148. Lefort, A., Baptista, M., Fantin, B., Depardieu, F., Arthur, M., Carbon, C., & Courvalin, P. (1999). Twostep acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis. Antimicrob Agents Chemother 43, 476–482.PubMedGoogle Scholar
  149. Lefort, A., Mainardi, J. L., Tod, M., & Lortholary, O. (2000a). Antienterococcal antibiotics. Med Clin North Am 84, 1471–1495.PubMedCrossRefGoogle Scholar
  150. Lefort, A., Saleh-Mghir, A., Garry, L., Carbon, C., & Fantin, B. (2000b). Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or-resistant Enterococcus faecalis. Antimicrob Agents Chemother 44, 3017–3021.PubMedGoogle Scholar
  151. Lewis, C. M., & Zervos, M. J. (1990). Clinical manifestations of enterococcal infection. Eur J Clin Microbiol Infect Dis 9, 111–117.PubMedCrossRefGoogle Scholar
  152. Liassine, N., Frei, R., Jan, I., & Auckenthaler, R. (1998). Characterization of glycopeptide-resistant enterococci from a Swiss hospital. J Clin Microbiol 36, 1853–1858.PubMedGoogle Scholar
  153. Linden, P. K., Pasculle, A. W., Manez, R., Kramer, D. J., Fung, J. J., Pinna, A. D., & Kusne, S. (1996). Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 22, 663–670.PubMedGoogle Scholar
  154. Livornese, L. L., Dias, S., Samel, C., Romanowski, B., Taylor, S., May, P., Pitsakis, P., Woods, G., Kaye, D., & Levison, M. E. (1992). Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 117, 112–116.PubMedGoogle Scholar
  155. Lodise, T. P., McKinnon, P. S., Tam, V H., & Rybak, M. J. (2002). Clinical outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus in a level 1 trauma center. Clin Infect Dis 34, 922–929.PubMedCrossRefGoogle Scholar
  156. Lu, H. Z., Weng, X. H., Li, H., Yin, Y. K., Pang, M. Y., & Tang, Y. W. (2002). Enterococcus faecium-related outbreak with molecular evidence of transmission from pigs to humans. J Clin Microbiol 40, 913–917.PubMedCrossRefGoogle Scholar
  157. Lucas, G. M., Lechtzin, N., Puryear, D. W., Yau, L. L., Flexner, C. W., & Moore, R. D. (1998). Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes. Clin Infect Dis 26, 1127–1133.PubMedGoogle Scholar
  158. Maki, D. G., & Agger, W. A. (1988). Enterococcal bacteremia: Clinical features, the risk of endocarditis, and management. Medicine (Baltimore), 67, 248–269.Google Scholar
  159. Marin, M. E., Mera, J. R., Arduino, R. C., Correa, A. P., Coque, T. M., Stamboulian, D., & Murray, B. E. (1998). First report of vancomycin-resistant Enterococcus faecium isolated in Argentina. Clin Infect Dis 26,235–236.PubMedCrossRefGoogle Scholar
  160. Marshall, C. G., Broadhead, G., Leskiw, B. K., & Wright, G. D. (1997). D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc Natl Acad Sci USA 94, 6480–6483.PubMedCrossRefGoogle Scholar
  161. Marshall, C. G., Lessard, I. A., Park, L, & Wright, G. D. (1998). Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob Agents Chemother 42, 2215–2220.PubMedGoogle Scholar
  162. Mathai, D., Jones, R. N., & Pfaller, M. A. (2001). Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: A report from the SEN-TRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 40, 129–136.PubMedCrossRefGoogle Scholar
  163. McCarthy, A. E., Victor, G., Ramotar, K., & Toye, B. (1994). Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital. J Clin Microbiol 32, 2671–2676.PubMedGoogle Scholar
  164. McDonald, L. C., Kuehnert, M. J., Tenover, F. C., & Jarvis, W. R. (1997). Vancomycin-resistant enterococci outside the health-care setting: Prevalence, sources, and public health implications. Emerg Infect Dis 3, 311–317.PubMedGoogle Scholar
  165. McDonald, L. C., Rossiter, S., Mackinson, C., Wang, Y. Y., Johnson, S., Sullivan, M., Sokolow, R., DeBess, E., Gilbert, L., Benson, J. A., Hill, B., & Angulo, F. J. (2001). Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. N Engl J Med 345, 1155–1160.PubMedCrossRefGoogle Scholar
  166. McKessar, S. J., Berry, A. M., Bell, J. M., Turnidge, J. D., & Paton, J. C. (2000). Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis. Antimicrob Agents Chemother 44, 3224–3228.PubMedCrossRefGoogle Scholar
  167. McNeil, S. A., Clark, N. M., Chandrasekar, P. H., & Kauffman, C. A. (2000). Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin). Clin Infect Dis 30, 403–404.PubMedCrossRefGoogle Scholar
  168. Megran, D. W. (1992). Enterococcal endocarditis. Clin Infect Dis 15, 63–71.PubMedGoogle Scholar
  169. Melhus, A., & Tjernberg, I. (1996). First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden. Scand J Infect Dis 28, 191–193.PubMedCrossRefGoogle Scholar
  170. Mevius, D., Devriese, L., Butaye, P., Vandamme, P., Verschure, M., & Veldman, K. (1998). Isolation of glycopeptide resistant Streptococcus gallolyticus strains with vanA, vanB, and both vanA and vanB genotypes from faecal samples of veal calves in The Netherlands. J Antimicrob Chemother 42, 275–276.PubMedCrossRefGoogle Scholar
  171. Miranda, A. G., Singh, K. V., & Murray, B. E. (1991). DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol 29, 2752–2757.PubMedGoogle Scholar
  172. Moellering, R. C., Jr. (1992). Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 14, 1173–1176.PubMedGoogle Scholar
  173. Moellering, R. C., Linden, P. K., Reinhardt, J., Blumberg, E. A., Bompart, F., & Talbot, G. H. (1999). The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid emergency-use study group. J Antimicrob Chemother 44, 251–261.PubMedGoogle Scholar
  174. Montecalvo, M. A., Horowitz, H., Gedris, C., Carbonaro, C., Tenover, F. C., Issah, A., Cook, P., & Wormser, G. P. (1994). Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 38, 1363–1367.PubMedGoogle Scholar
  175. Montecalvo, M. A., Horowitz, H., Wormser, G. P., Seiter, K., & Carbonaro, C. A. (1995). Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 39, 794.PubMedGoogle Scholar
  176. Montecalvo, M. A., Jarvis, W. R., Uman, J., Shay, D. K., Petrullo, C., Rodney, K., Gedris, C., Horowitz, H. W., & Wormser, G. P. (1999). Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 131, 269–272.PubMedGoogle Scholar
  177. Moreno, F., Grota, P., Crisp, C., Magnon, K., Melcher, G. P., Jorgensen, J. H., & Patterson, J. E. (1995). Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 21, 1234–1237.PubMedGoogle Scholar
  178. Morris, J. G., Jr., Shay, D. K., Hebden, J. N., McCarter, R. J., Jr., Perdue, B. E., Jarvis, W, Johnson, J. A., Dowling, T. C., Polish, L. B., & Schwalbe, R. S. (1995). Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 123, 250–259.PubMedGoogle Scholar
  179. Mundy, L. M., Sahm, D. F., & Gilmore, M. (2000). Relationships between enterococcal virulence and antimicrobial resistance. Clin Microbiol Rev 13, 513–522.PubMedCrossRefGoogle Scholar
  180. Murphy, T. M., Deitz, J. M., Petersen, P. J., Mikels, S. M., & Weiss, W. J. (2000). Therapeutic efficacy of GAR-936, a novel glycylcycline, in a rat model of experimental endocarditis. Antimicrob Agents Chemother 44, 3022–3027.PubMedCrossRefGoogle Scholar
  181. Murray, B. E. (1990). The life and times of the Enterococcus. Clin Microbiol Rev 3, 46–65.PubMedGoogle Scholar
  182. Murray, B. E. (1994). Can antibiotic resistance be controlled? [letter; comment]. N Engl J Med 330, 1229–1230.PubMedCrossRefGoogle Scholar
  183. Murray, B. E. (1997). Vancomycin-resistant enterococci. Am J Med 102, 284–293.PubMedCrossRefGoogle Scholar
  184. Murray, B. E., & Mederski-Samaroj, B. (1983). Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest 72, 1168–1171.PubMedGoogle Scholar
  185. Murray, B. E., Singh, K. V, Markowitz, S. M., Lopardo, H. A., Patterson, J. E., Zervos, M. J., Rubeglio, E., Eliopoulos, G. M., Rice, L. B., & Goldstein, F. W. (1991). Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis 163, 780–785.PubMedGoogle Scholar
  186. Mylotte, J. M., Goodnough, S., & Tayara, A. (2001). Antibiotic-resistant organisms among long-term care facility residents on admission to an inpatient geriatrics unit: Retrospective and prospective surveillance. Am J Infect Control 29, 139–144.PubMedGoogle Scholar
  187. Nachman, S. A., Verma, R., & Egnor, M. (1995). Vancomycin-resistant Enterococcus faecium shunt infection in an infant: An antibiotic cure. Microb Drug Resist 1, 95–96.PubMedGoogle Scholar
  188. Nannini, E. C., Singh, K. V, & Murray, B. E. (2001, December 16–19). Efficacy of GAR-936, a novel glycylcycline, against enterococci in a mouse peritonitis model. Proceedings of 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Abstract No. B-1651). Chicago, IL. Washington, DC: American Society for Microbiology.Google Scholar
  189. Navarro, F., & Courvalin, P. (1994). Analysis of genes encoding d-alanine-d-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother 38, 1788–1793.PubMedGoogle Scholar
  190. Neely, A. N., & Maley, M. P. (2000). Survival of enterococci and staphylococci on hospital fabrics and plastic, [see comments]. J Clin Microbiol 38, 724–726.PubMedGoogle Scholar
  191. NNIS. (2000). National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992–April 2000, issued June 2000. Am J Infect Control 28, 429–448.Google Scholar
  192. NNIS. (2001). National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992–June 2001, issued August 2001. Am J Infect Control 29, 404–421.Google Scholar
  193. Noble, W. C., Virani, Z., & Cree, R. G. (1992). Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 72, 195–198.PubMedGoogle Scholar
  194. Noskin, G. A., Peterson, L. R., & Warren, J. R. (1995a). Enterococcus faecium and Enterococcus faecalis bacteremia: Acquisition and outcome. Clin Infect Dis 20, 296–301.PubMedGoogle Scholar
  195. Noskin, G. A., Stosor, V., Cooper, I., & Peterson, L. R. (1995b). Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces [see comments]. Infect Control Hosp Epidemiol 16, 577–581.PubMedGoogle Scholar
  196. Nourse, C., Byrne, C., Kaufmann, M., Keane, C. T., Fenelon, L., Smyth, E. G., Hone, R., & Butler, K. (2000). VRE in the Republic of Ireland: Clinical significance, characteristics and molecular similarity of isolates. J Hosp Infect 44, 288–293.PubMedGoogle Scholar
  197. O’Donovan, C. A., Fan-Havard, P., Tecson-Tumang, F. T., Smith, S. M., & Eng, R. H. (1994). Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 18, 105–109.Google Scholar
  198. Olsen, R. J., Lynch, P., Coyle, M. B., Cummings, J., Bokete, T., & Stamm, W. E. (1993). Examination gloves as barriers to hand contamination in clinical practice. JAMA 270, 350–353.PubMedCrossRefGoogle Scholar
  199. Ostrowsky, B. E., Clark, N. C., Thauvin-Eliopoulos, C., Venkataraman, L., Samore, M. H., Tenover, F. C., Eliopoulos, G. M., Moellering, R. C., Jr., & Gold, H. S. (1999). A cluster of VanD vancomycin-resistant Enterococcus faecium: Molecular characterization and clinical epidemiology. J Infect Dis 180, 1177–1185.PubMedCrossRefGoogle Scholar
  200. Ostrowsky, B. E., Trick, W. E., Sohn, A. H., Quirk, S. B., Holt, S., Carson, L. A., Hill, B. C., Arduino, M. J., Kuehnert, M. J., & Jarvis, W. R. (2001). Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 344, 1427–1433.PubMedCrossRefGoogle Scholar
  201. O’Toole, R. D., Drew, W. L., Dahlgren, B. J., & Beaty, H. N. (1970). An outbreak of methicillin-resistant Staphylococcus aureus infection. Observations in hospital and nursing home. JAMA 213, 257–263.Google Scholar
  202. Pallares, R., Pujol, M., Pena, C., Ariza, J., Martin, R., & Gudiol, F. (1993). Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study. Arch Intern Med 153, 1581–1586.PubMedCrossRefGoogle Scholar
  203. Papanicolaou, G. A., Meyers, B. R., Meyers, J., Mendelson, M. H., Lou, W., Emre, S., Sheiner, P., & Miller, C. (1996). Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: Risk factors for acquisition and mortality. Clin Infect Dis 23, 760–766.PubMedGoogle Scholar
  204. Patel, R. (2000). Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms. FEMS Microbiol Lett 185, 1–7.PubMedGoogle Scholar
  205. Patel, R., Piper, K., Cockerill, F. R., 3rd, Steckelberg, J. M., & Yousten, A. A. (2000). The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal vanA vancomycin resistance gene cluster. Antimicrob Agents Chemother 44, 705–709.PubMedGoogle Scholar
  206. Patel, R., Rouse, M. S., Piper, K. E., & Steckelberg, J. M. (2001). Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis. Antimicrob Agents Chemother 45, 621–623.PubMedCrossRefGoogle Scholar
  207. Patel, R., Uhl, J. R., Kohner, P., Hopkins, M. K., & Cockerill, F. R., 3rd. (1997a). Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci. J Clin Microbiol 35, 703–707.PubMedGoogle Scholar
  208. Patel, S. S., Balfour, J. A., & Bryson, H. M. (1997b). Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53, 637–656.PubMedGoogle Scholar
  209. Patterson, J. E., Sweeney, A. H., Simms, M., Carley, N., Mangi, R., Sabetta, J., & Lyons, R. W. (1995). An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore), 74, 191–200.CrossRefGoogle Scholar
  210. Perez Mato, S., Robinson, S., & Begue, R. E. (1999). Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol. Pediatr Infect Dis J 18, 483–484.PubMedGoogle Scholar
  211. Perichon, B., Casadewall, B., Reynolds, P., & Courvalin, P. (2000). Glycopeptide-resistant Enterococcus faecium BM4416 is a VanD-type strain with an impaired d-Alanine:d-Alanine ligase. Antimicrob Agents Chemother 44, 1346–1348.PubMedCrossRefGoogle Scholar
  212. Perichon, B., Reynolds, P., & Courvalin, P. (1997). VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 41, 2016–2018.PubMedGoogle Scholar
  213. Peset, V., Tallon, P., Sola, C., Sanchez, E., Sarrion, A., Perez-Belles, C., Vindel, A., Canton, E., & Gobernado, M. (2000). Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis 19, 742–749.PubMedCrossRefGoogle Scholar
  214. Power, E. G., Abdulla, Y. H., Talsania, H. G., Spice, W., Aathithan, S., & French, G. L. (1995). vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother 36, 595–606.PubMedGoogle Scholar
  215. Poyart, C., Pierre, C., Quesne, G., Pron, B., Berche, P., & Trieu-Cuot, P. (1997). Emergence of vancomycin resistance in the genus Streptococcus: Characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother 41, 24–29.PubMedGoogle Scholar
  216. Prystowsky, J., Siddiqui, E., Chosay, J., Shinabarger, D. L., Millichap, I, Peterson, L. R., & Noskin, G. A. (2001). Resistance to linezolid: Characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 45, 2154–2156.PubMedCrossRefGoogle Scholar
  217. Quale, J., Landman, D., Saurina, G., Atwood, E., DiTore, V., & Patel, K. (1996). Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 23, 1020–1025.PubMedGoogle Scholar
  218. Rafferty, M. E., McCormick, M. I., Bopp, L. H., Baltch, A. L., George, M., Smith, R. P., Rheal, C., Ritz, W., & Schoonmaker, D. (1997). Vancomycin-resistant enterococci in stool specimens submitted for Clostridium difficile cytotoxin assay. Infect Control Hosp Epidemiol 18, 342–344.PubMedGoogle Scholar
  219. Rasmussen, B. A., Gluzman, Y, & Tally, F. P. (1994). Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines. Antimicrob Agents Chemother 38, 1658–1660.PubMedGoogle Scholar
  220. Reid, K. C., Cockerill, I. F., & Patel, R. (2001). Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: A report of 20 cases. Clin Infect Dis 32, 1540–1546.PubMedCrossRefGoogle Scholar
  221. Reynolds, P. E. (1989). Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 8, 943–950.PubMedCrossRefGoogle Scholar
  222. Reynolds, P. E., Ambur, O. H., Casadewall, B., & Courvalin, P. (2001). The Van YD D,D-carboxypeptidase of Enterococcus faecium BM4339 is a penicillin-binding protein. Microbiol 147, 2571–2578.Google Scholar
  223. Reynolds, P. E., & Somner, E. A. (1990). Comparison of the target sites and mechanisms of action of glycopeptide and lipoglycodepsipeptide antibiotics. Drugs Exp Clin Res 16, 385–389.PubMedGoogle Scholar
  224. Rice, L. B., Carias, L. L., Donskey, C. L., & Rudin, S. D. (1998). Transferable, plasmid-mediated VanB-type glycopeptide resistance in Enterococcus faecium. Antimicrob Agents Chemother 42, 963–964.PubMedGoogle Scholar
  225. Rippere, K., Patel, R., Uhl, J. R., Piper, K. E., Steckelberg, J. M., Kline, B. C., Cockerill, F. R., 3rd, and Yousten, A. A. (1998). DNA sequence resembling vanA and vanB in the vancomycin-resistant biopesticide Bacillus popilliae. J Infect Dis 178, 584–588.PubMedGoogle Scholar
  226. Roberts, M.C., Sutcliffe, J., Courvalin, P., Jensen, L.B., Rood, J., & Seppala, H. (1999). Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 43, 2823–2830.PubMedGoogle Scholar
  227. Robredo, B., Singh, K. V., Baquero, F., Murray, B. E., & Torres, C. (2000a). Vancomycin-resistant enterococci isolated from animals and food. Int J Food Microbiol 54, 197–204.PubMedCrossRefGoogle Scholar
  228. Robredo, B., Singh, K. V., Torres, C., & Murray, B. E. (2000b). Streptogramin resistance and shared pulsed-field gel electrophoresis patterns in vanA-containing Enterococcus faecium and Enterococcus hirae isolated from humans and animals in Spain. Microb Drug Resist 6, 305–311.PubMedGoogle Scholar
  229. Robredo, B., Torres, C., Singh, K. V, & Murray, B.E. (2000c). Molecular analysis of Tn1546 in vanA-containing Enterococcus spp. isolated from humans and poultry. Antimicrob Agents Chemother 44, 2588–2589.PubMedCrossRefGoogle Scholar
  230. Roghmann, M.C., McCarter, R.J., Jr., Brewrink, J., Cross, A.S., & Morris, J.G., Jr. (1997). Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. Clin Infect Dis 25, 1056–1059.PubMedGoogle Scholar
  231. Rubin, L. G., Tucci, V., Cercenado, E., Eliopoulos, G., & Isenberg, H. D. (1992). Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 13, 700–705.PubMedGoogle Scholar
  232. Safdar, A., Bryan, C. S., Stinson, S., & Saunders, D. E. (2002). Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium: Treatment with chloramphenicol plus minocycline. Clin Infect Dis 34, E61–63.PubMedCrossRefGoogle Scholar
  233. Sahm, D. F., Kissinger, J., Gilmore, M. S., Murray, P. R., Mulder, R., Solliday, J., & Clarke, B. (1989). In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 33, 1588–1591.PubMedGoogle Scholar
  234. Saleh-Mghir, A., Lefort, A., Petegnief, Y., Dautrey, S., Vallois, J. M., Le Guludec, D., Carbon, C., & Fantin, B.(1999). Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 43, 115–120.PubMedGoogle Scholar
  235. Schleifer, K.H., & Kilpper-Bälz, R. (1984). Transfer of Streptococcus faecalis and Streptococcus faecium to the genus Enterococcus nom. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb. nov. Int J Syst Bacteriol 34, 31–34.Google Scholar
  236. Schouten, M. A., Hoogkamp-Korstanje, J. A., Meis, J. F., & Voss, A. (2000). Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 19, 816–822.PubMedCrossRefGoogle Scholar
  237. Schwalbe, R. S., McIntosh, A. C., Qaiyumi, S., Johnson, J. A., Johnson, R. J., Furness, K. M., Holloway, W. J., & Steele-Moore, L. (1996). In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrob Agents Chemother 40, 2416–2419.PubMedGoogle Scholar
  238. Schwalbe, R. S., McIntosh, A. C., Qaiyumi, S., Johnson, J. A., & Morris, J. G., Jr. (1999). Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet 353, 722.PubMedCrossRefGoogle Scholar
  239. Seetulsingh, P. S., Tomayko, J. F., Coudron, P. E., Markowitz, S. M., Skinner, C., Singh, K. V., & Murray, B.E.(1996). Chromosomal DNA restriction endonuclease digestion patterns of beta-lactamase-producing Enterococcus faecalis isolates collected from a single hospital over a 7-year period. J Clin Microbiol 34, 1892–1896.PubMedGoogle Scholar
  240. Shaikh, Z. H., Peloquin, C. A., & Ericsson, C. D. (2001). Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: Case report and literature review. Scand J Infect Dis 33, 375–379.PubMedGoogle Scholar
  241. Shay, D.K., Maloney, S.A., Montecalvo, M., Banerjee, S., Wormser, G.P., Arduino, M.J., Bland, L. A., & Jarvis, W.R. (1995). Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 172, 993–1000.PubMedGoogle Scholar
  242. Sherman, J. M. (1937). The streptococci. Bacterial Rev 1, 3–97.Google Scholar
  243. Shinabarger, D. L., Marotti, K. R., Murray, R. W., Lin, A. H., Melchior, E. P., Swaney, S. M., Dunyak, D. S., Demyan, W. F., & Buysse, J. M. (1997). Mechanism of action of oxazolidinones: Effects of linezolid and eperezolid on translation reactions. Antimicrob Agents Chemother 41, 2132–2136.PubMedGoogle Scholar
  244. Shlaes, D. M., Levy, J., & Wolinsky, E. (1981). Enterococcal bacteremia without endocarditis. Arch Intern Med 141, 578–581.PubMedCrossRefGoogle Scholar
  245. Singh, K. V., Weinstock, G. M., & Murray, B. E. (2002). An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob Agents Chemother 46, 1845–1850.PubMedCrossRefGoogle Scholar
  246. Slaughter, S., Hayden, M. K., Nathan, C., Hu, T. C., Rice, T., Van Voorhis, J., Matushek, M., Franklin, C., & Weinstein, R. A. (1996). A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 125, 448–456.PubMedGoogle Scholar
  247. Soltani, M., Beighton, D., Philpott-Howard, J., & Woodford, N. (2000). Mechanisms of resistance to quinupristin-dalfopristin among isolates of Entemcoccus faecium from animals, raw meat, and hospital patients in Western Europe. Antimicrob Agents Chemother 44, 433–436.PubMedCrossRefGoogle Scholar
  248. Steinmetz, M. P., Vogelbaum, M. A., De Georgia, M. A., Andrefsky, J. C., & Isada, C. (2001). Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: Case report and review of the literature. Crit Care Med 29, 2383–2385.PubMedGoogle Scholar
  249. Stinear, T. P., Olden, D. C., Johnson, P. D., Davies, J. K., & Grayson, M. L. (2001). Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet 357, 855–856.PubMedCrossRefGoogle Scholar
  250. Stosor, V., Peterson, L. R., Postelnick, M., & Noskin, G. A. (1998). Enterococcus faecium bacteremia: Does vancomycin resistance make a difference? Arch Intern Med 158, 522–527.PubMedCrossRefGoogle Scholar
  251. Stroud, L., Edwards, J., Danzing, L., Culver, D., & Gaynes, R. (1996). Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol 17, 576–580.PubMedCrossRefGoogle Scholar
  252. Suppola, J. P., Kuikka, A., Vaara, M., & Valtonen, V. V. (1998). Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia. Scand J Infect Dis 30, 153–157.PubMedGoogle Scholar
  253. Tally, F. P., & DeBruin, M. F. (2000). Development of daptomycin for Gram-positive infections. J Antimicrob Chemother 46, 523–526.PubMedCrossRefGoogle Scholar
  254. Taylor, S. E., Paterson, D. L., & Yu, V. L. (1998). Treatment options for chronic prostatitis due to vancomycin-resistant Enterococcus faecium. Eur J Clin Microbiol Infect Dis 17, 798–800.PubMedGoogle Scholar
  255. Tenorio, A. R., Badri, S. M., Sahgal, N. B., Hota, B., Matushek, M., Hayden, M. K., Trenholme, G. M., & Weinstein, R. A. (2001). Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin Infect Dis 32, 826–829.PubMedCrossRefGoogle Scholar
  256. Tokars, J. I., Satake, S., Rimland, D., Carson, L., Miller, E. R., Killum, E., Sinkowitz-Cochran, R. L., Arduino, M. J., Tenover, F. C., Marston, B., & Jarvis, W. R. (1999). The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans’ Affairs institution. Infect Control Hosp Epidemiol 20, 171–175.PubMedGoogle Scholar
  257. Tornieporth, N. G., Roberts, R. B., John, J., Hafner, A., & Riley, L. W. (1996). Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 23, 767–772.PubMedGoogle Scholar
  258. Trick, W. E., Kuehnert, M. J., Quirk, S. B., Arduino, M. J., Aguero, S. M., Carson, L. A., Hill, B. C., Banerjee, S. N., & Jarvis, W. R. (1999). Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients. J Infect Dis 180, 391–396.PubMedCrossRefGoogle Scholar
  259. Uttley, A. H., Collins, C. H., Naidoo, J., & George, R. C. (1988). Vancomycin-resistant enterococci. Lancet 1, 57–58.PubMedGoogle Scholar
  260. Uttley, A. H., George, R. C., Naidoo, J., Woodford, N., Johnson, A. P., Collins, C. H., Morrison, D., Gilfillan, A. J., Fitch, L. E., & Heptonstall, J. (1989). High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 103, 173–181.PubMedCrossRefGoogle Scholar
  261. Van Bambeke, F., Chauvel, M., Reynolds, P. E., Fraimow, H. S., & Courvalin, P. (1999). Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants. Antimicrob Agents Chemother 43, 41–47.PubMedGoogle Scholar
  262. Van Caeseele, P., Giercke, S., Wylie, J., Boyd, D., Mulvey, M., Amin, S., & Ofner-Agostini, M. (2001). Identification of the first vancomycin-resistant Enterococcus faecalis harbouring vanE in Canada. Can Commun Dis Rep 27, 101–104.PubMedGoogle Scholar
  263. van den Bogaard, A. E., Jensen, L. B., & Stobberingh, E. E. (1997a). Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med 337, 1558–1559.PubMedGoogle Scholar
  264. van den Bogaard, A. E., Mertens, P., London, N. H., & Stobberingh, E. E. (1997b). High prevalence of colonization with vancomycin-and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: Is the addition of antibiotics to animal feeds to blame? J Antimicrob Chemother 40, 454–456.PubMedGoogle Scholar
  265. van den Bogaard, A. E., & Stobberingh, E. E. (2000). Epidemiology of resistance to antibiotics. Links between animals and humans. Int J Antimicrob Agents 14, 327–335.PubMedGoogle Scholar
  266. van den Braak, N., Ott, A., van Belkum, A., Kluytmans, J. A., Koeleman, J. G., Spanjaard, L., Voss, A., Weersink, A. J., Vandenbroucke-Grauls, C. M., Buiting, A. G., Verbrugh, H. A., & Endtz, H. P. (2000). Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands. Infect Control Hosp Epidemiol 21, 520–524.PubMedGoogle Scholar
  267. Van der Auwera, P., Pensart, N., Korten, V., Murray, B. E., & Leclercq, R. (1996). Influence of oral glycopeptides on the fecal flora of human volunteers: Selection of highly glycopeptide-resistant enterococci. J Infect Dis 173, 1129–1136.PubMedGoogle Scholar
  268. Vandamme, P., Vercauteren, E., Lammens, C., Pensart, N., Leven, M., Pot, B., Leclercq, R., & Goossens, H. (1996). Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol 34, 2572–2576.PubMedGoogle Scholar
  269. Venditti, M., Fimiani, C., Baiocchi, P., Santini, C., Tarasi, A., Capone, A., Di Rosa, R., & Micozzi, A. (1994). Infections by ampicillin-resistant enterococci: A case-control study. J Chemother 6, 121–126.PubMedGoogle Scholar
  270. Vergis, E. N., Hayden, M. K., Chow, J. W., Snydman, D. R., Zervos, M. J., Linden, P. K., Wagener, M. M., Schmitt, B., & Muder, R. R. (2001). Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: A prospective multicenter study. Ann Intern Med 135, 484–92.PubMedGoogle Scholar
  271. Viagappan, M., & Holliman, R. E. (1999), Risk factors for acquisition of gentamicin-resistant enterococcal infection: A case-controlled study. Postgrad Med J 75, 342–345.PubMedGoogle Scholar
  272. Watanakunakorn, C., & Bakie, C. (1973). Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci. Antimicrob Agents Chemother 4, 120–124.PubMedGoogle Scholar
  273. Weinstein, M. R., Dedier, H., Brunton, J., Campbell, I., & Conly, J. M. (1999). Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 29, 361–366.PubMedGoogle Scholar
  274. Wells, C. L., Juni, B. A., Cameron, S. B., Mason, K. R., Dunn, D. L., Ferrieri, P., & Rhame, F. S. (1995). Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 21, 45–50.PubMedGoogle Scholar
  275. Wells, L. D., & von Graevenitz, A. (1980). Clinical significance of enterococci in blood cultures from adult patients. Infection 8, 147–151.PubMedCrossRefGoogle Scholar
  276. Wells, V D., Wong, E. S., Murray, B. E., Coudron, P. E., Williams, D. S., & Markowitz, S. M. (1992). Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med 116, 285–292.PubMedGoogle Scholar
  277. Wilke, W. W., Marshall, S. A., Coffman, S. L., Pfaller, M. A., Edmund, M. B., Wenzel, R. P., & Jones, R. N. (1997). Vancomycin-resistant Enterococcus raffinosus: Molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program. Diagn Microbiol Infect Dis 29, 43–49.PubMedCrossRefGoogle Scholar
  278. Willems, R. J., Top, J., van den Braak, N., van Belkum, A., Mevius, D. J., Hendriks, G., van Santen-Verheuvel, M., & van Embden, J. D. (1999). Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother 43, 483–491.PubMedGoogle Scholar
  279. Willey, B. M., Kreiswirth, B. N., Simor, A. E., Faur, Y., Patel, M., Williams, G., & Low, D. E. (1993). Identification and characterization of multiple species of vancomycin-resistant enterococci, including an evaluation of Vitek software version 7.1. J Clin Microbiol 31, 2777–2779.PubMedGoogle Scholar
  280. Williamson, J. C., Glazier, S. S., & Peacock, J. E., Jr. (2002). Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/dalfopristin. Clin Neurol Neurosurg 104, 54–56.PubMedCrossRefGoogle Scholar
  281. Winston, D. J., Emmanouilides, C., Kroeber, A., Hindler, J., Bruckner, D. A., Territo, M. C., & Busuttil, R. W. (2000). Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 30, 790–797.PubMedGoogle Scholar
  282. Wong, A. H., Wenzel, R. P., & Edmond, M. B. (2000). Epidemiology of bacteriuria caused by vancomycin-resistant enterococci-A retrospective study. Am J Infect Control 28, 277–281.PubMedCrossRefGoogle Scholar
  283. Wong, M. T., Kauffman, C. A., Standiford, H. C., Linden, P., Fort, G., Fuchs, H. J., Porter, S. B., & Wenzel, R. P. (2001). Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 33, 1476–1482.PubMedGoogle Scholar
  284. Woodford, N., Adebiyi, A. M., Palepou, M. F., & Cookson, B. D. (1998). Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob Agents Chemother 42, 502–508.PubMedGoogle Scholar
  285. Woodford, N., Jones, B. L., Baccus, Z., Ludlam, H. A., & Brown, D. F. (1995). Linkage of vancomycin and high-level gentamicin resistance genes on the same plasmid in a clinical isolate of Enterococcus faecalis. J Antimicrob Chemother 35, 179–184.PubMedGoogle Scholar
  286. Zanella, R. C., Valdetaro, F., Lovgren, M., Tyrrel, G. J., Bokermann, S., Almeida, S. C., Vieira, V. S., & Brandileone, M. C. (1999). First confirmed case of a vancomycin-resistant Enterococcus faecium with VanA phenotype from Brazil: Isolation from a meningitis case in Sao Paulo. Microb Drug Resist 5, 159–162.PubMedCrossRefGoogle Scholar
  287. Zeana, C., Kubin, C. J., Della-Latta, P., & Hammer, S. M. (2001). Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: Case report and review of the literature. Clin Infect Dis 33, 477–482.PubMedCrossRefGoogle Scholar
  288. Zervos, M. J., Dembinski, S., Mikesell, T., & Schaberg, D. R. (1986). High-level resistance to gentamicin in Streptococcus faecalis: Risk factors and evidence for exogenous acquisition of infection. J Infect Dis 153, 1075–1083.PubMedGoogle Scholar
  289. Zervos, M. J., Kauffman, C. A., Therasse, P. M., Bergman, A. G., Mikesell, T. S., & Schaberg, D. R. (1987). Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med 106, 687–691.PubMedGoogle Scholar
  290. Zhanel, G. G., Hoban, D. J., & Karlowsky, J. A. (2001). Nitrofurantoin is active against vancomycin-resistant enterococci. Antimicrob Agents Chemother 45, 324–326.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Esteban C. Nannini
  • Barbara E. Murray

There are no affiliations available

Personalised recommendations